Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabrina Garbo

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Cell Death & Disease|June 15, 2026
Interplay between the RBP SYNCRIP and RNA methylation in determining sEV miRNA-cargo and function in cell-to-cell communicationLuca Quattrocchi, Sabrina Garbo, Francesco Marocco, et al.
Oncotarget|April 13, 2018
The lncRNA H19 positively affects the tumorigenic properties of glioblastoma cells and contributes to NKD1 repression through the recruitment of EZH2 on its promoterBarbara Fazi, Sabrina Garbo, Nicola Toschi, et al.
Elife|July 2, 2025
Negative regulation of miRNA sorting into EVs is mediated by the capacity of RBP PCBP2 to impair the SYNCRIP-dependent miRNA loadingFrancesco Marocco, Sabrina Garbo, Claudia Montaldo, et al.
Cell Death & Disease|November 17, 2022
Restoration of WT1/miR-769-5p axis by HDAC1 inhibition promotes MMT reversal in mesenchymal-like mesothelial cellsGiulio Bontempi, Michela Terri, Sabrina Garbo, et al.
Cell Death & Disease|August 30, 2025
Long noncoding RNA H19 promotes the acquisition of a mesenchymal-like invasive phenotype in mesothelial primary cells through an HDAC1-mediated WT1/Sp1 switchGiulio Bontempi, Federica Michetti, Michela Terri, et al.
Bioorganic Chemistry|July 30, 2024
Unlocking the potential of higher-molecular-weight 5-HT<sub>7</sub>R ligands: Synthesis, affinity, and ADMET examinationPatryk Pyka, Sabrina Garbo, Aleksandra Murzyn, et al.
Journal of Medicinal Chemistry|July 13, 2023
Novel 1,4-Dihydropyridines as Specific Binders and Activators of SIRT3 Impair Cell Viability and Clonogenicity and Downregulate Hypoxia-Induced Targets in Cancer CellsClemens Zwergel, Michele Aventaggiato, Sabrina Garbo, et al.
European Journal of Medicinal Chemistry|September 30, 2022
Seleno-vs. thioether triazine derivatives in search for new anticancer agents overcoming multidrug resistance in lymphomaWesam Ali, Sabrina Garbo, Annamária Kincses, et al.
ACS Chemical Neuroscience|February 28, 2025
Procognitive Potential of Neuroprotective Triazine 5-HT<sub>6</sub> Receptor Antagonists Tested on Chronic Activity In Vivo in Rats: Computer-Aided Insight into the Role of Chalcogen-Differences on the Pharmacological ProfileMagdalena Jastrzębska-Więsek, Sabrina Garbo, Agnieszka Cios, et al.
Journal of Medicinal Chemistry|January 8, 2024
First-in-Class Selenium-Containing Potent Serotonin Receptor 5-HT<sub>6</sub> Agents with a Beneficial Neuroprotective Profile against Alzheimer's DiseasePatryk Pyka, Wawrzyniec Haberek, Małgorzata Więcek, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Cell Death & Disease|June 15, 2026
Interplay between the RBP SYNCRIP and RNA methylation in determining sEV miRNA-cargo and function in cell-to-cell communicationLuca Quattrocchi, Sabrina Garbo, Francesco Marocco, et al.
Oncotarget|April 13, 2018
The lncRNA H19 positively affects the tumorigenic properties of glioblastoma cells and contributes to NKD1 repression through the recruitment of EZH2 on its promoterBarbara Fazi, Sabrina Garbo, Nicola Toschi, et al.
Elife|July 2, 2025
Negative regulation of miRNA sorting into EVs is mediated by the capacity of RBP PCBP2 to impair the SYNCRIP-dependent miRNA loadingFrancesco Marocco, Sabrina Garbo, Claudia Montaldo, et al.
Cell Death & Disease|November 17, 2022
Restoration of WT1/miR-769-5p axis by HDAC1 inhibition promotes MMT reversal in mesenchymal-like mesothelial cellsGiulio Bontempi, Michela Terri, Sabrina Garbo, et al.
Cell Death & Disease|August 30, 2025
Long noncoding RNA H19 promotes the acquisition of a mesenchymal-like invasive phenotype in mesothelial primary cells through an HDAC1-mediated WT1/Sp1 switchGiulio Bontempi, Federica Michetti, Michela Terri, et al.
Bioorganic Chemistry|July 30, 2024
Unlocking the potential of higher-molecular-weight 5-HT<sub>7</sub>R ligands: Synthesis, affinity, and ADMET examinationPatryk Pyka, Sabrina Garbo, Aleksandra Murzyn, et al.
Journal of Medicinal Chemistry|July 13, 2023
Novel 1,4-Dihydropyridines as Specific Binders and Activators of SIRT3 Impair Cell Viability and Clonogenicity and Downregulate Hypoxia-Induced Targets in Cancer CellsClemens Zwergel, Michele Aventaggiato, Sabrina Garbo, et al.
European Journal of Medicinal Chemistry|September 30, 2022
Seleno-vs. thioether triazine derivatives in search for new anticancer agents overcoming multidrug resistance in lymphomaWesam Ali, Sabrina Garbo, Annamária Kincses, et al.
ACS Chemical Neuroscience|February 28, 2025
Procognitive Potential of Neuroprotective Triazine 5-HT<sub>6</sub> Receptor Antagonists Tested on Chronic Activity In Vivo in Rats: Computer-Aided Insight into the Role of Chalcogen-Differences on the Pharmacological ProfileMagdalena Jastrzębska-Więsek, Sabrina Garbo, Agnieszka Cios, et al.
Journal of Medicinal Chemistry|January 8, 2024
First-in-Class Selenium-Containing Potent Serotonin Receptor 5-HT<sub>6</sub> Agents with a Beneficial Neuroprotective Profile against Alzheimer's DiseasePatryk Pyka, Wawrzyniec Haberek, Małgorzata Więcek, et al.
Pageof 2